We are live on
!
Find out more
CAC
Core Alternative Capital Portfolio holdings
AUM
$339M
1-Year Est. Return
18.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.38%
1 Year Est. Return
+18.22%
3 Year Est. Return
+57.45%
5 Year Est. Return
+82.24%
10 Year Est. Return
–
AUM
$558M
AUM Growth
-$25.3M
(-4.3%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-10.98%
Top 10 Holdings %
Top 10 Hldgs %
30.28%
Holding
381
New
17
Increased
25
Reduced
294
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$447K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$403K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$288K |
| 4 |
Medtronic
MDT
|
+$286K |
| 5 |
TE Connectivity
TEL
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.75M |
| 2 |
Microsoft
MSFT
|
+$3M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.91M |
| 4 |
Merck
MRK
|
+$2.52M |
| 5 |
Broadridge
BR
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.14% |
| 2 | Financials | 15.17% |
| 3 | Healthcare | 13.18% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Westlake Corp
WLK
$9.46B
| $1.07K | ﹤0.01% |
7
-100
| -93% | -$14.1K |
|
302
Agilent Technologies
A
$39.1B
| $1.02K | ﹤0.01% |
7
-87
| -93% | -$11.9K |
|
303
IQVIA
IQV
$34.7B
| $1.01K | ﹤0.01% |
4
-59
| -94% | -$13.8K |
|
304
Dow Inc
DOW
$21.6B
| $985 | ﹤0.01% |
17
-225
| -93% | -$12.4K |
|
305
Xcel Energy
XEL
$51B
| $968 | ﹤0.01% |
18
-172
| -91% | -$9.82K |
|
306
Verisk Analytics
VRSK
$26.4B
| $943 | ﹤0.01% |
4
-43
| -91% | -$10.3K |
|
|
FITB
307
Fifth Third Bancorp
FITB
$52B
| $893 | ﹤0.01% |
24
-206
| -90% | -$7.17K |
|
308
ESAB
ESAB
$5.25B
| $885 | ﹤0.01% |
8
-95
| -92% | -$8.87K |
|
309
Equity Residential
EQR
$25.4B
| $884 | ﹤0.01% |
14
-121
| -90% | -$7.37K |
|
310
Archer Daniels Midland
ADM
$41.4B
| $879 | ﹤0.01% |
14
-212
| -94% | -$12.4K |
|
311
Ameriprise Financial
AMP
$46.8B
| $877 | ﹤0.01% |
2
-31
| -94% | -$12.4K |
|
312
Boston Properties
BXP
$11B
| $849 | ﹤0.01% |
13
-90
| -87% | -$5.96K |
|
313
General Mills
GIS
$19.2B
| $840 | ﹤0.01% |
12
-205
| -94% | -$13.3K |
|
314
Constellation Brands
STZ
$22.2B
| $815 | ﹤0.01% |
3
-43
| -93% | -$10.9K |
|
315
State Street
STT
$50.9B
| $696 | ﹤0.01% |
9
-101
| -92% | -$7.49K |
|
|
ANSS
316
DELISTED
Ansys
ANSS
| $694 | ﹤0.01% |
2
-21
| -91% | -$7.11K |
|
317
Humana
HUM
$46.7B
| $693 | ﹤0.01% |
2
-65
| -97% | -$24.6K |
|
318
International Flavors & Fragrances
IFF
$19.4B
| $688 | ﹤0.01% |
8
-82
| -91% | -$6.58K |
|
319
Global Payments
GPN
$22.1B
| $668 | ﹤0.01% |
5
-87
| -95% | -$11.5K |
|
320
Best Buy
BBY
$18B
| $656 | ﹤0.01% |
8
-82
| -91% | -$6.24K |
|
321
Tyson Foods
TSN
$20.2B
| $646 | ﹤0.01% |
11
-150
| -93% | -$8.22K |
|
322
Enovis
ENOV
$1.56B
| $625 | ﹤0.01% |
10
-132
| -93% | -$7.9K |
|
323
Illumina
ILMN
$29.4B
| $549 | ﹤0.01% |
4
-61
| -94% | -$8.18K |
|
324
Moderna
MRNA
$21.5B
| $533 | ﹤0.01% |
5
-120
| -96% | -$12.1K |
|
325
Southwest Airlines
LUV
$22.1B
| $525 | ﹤0.01% |
18
-188
| -91% | -$5.82K |
|
Similar funds
PB
CWM
BAM
WCM
VCM
BCM
SCM
JCIA
Core Alternative Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Core Alternative Capital held 381 positions worth $558M, down 4.3% from $583M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Core Alternative Capital withdrew a net $61.3M in Q1 2024, closing 27 positions and reducing 294 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $543K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Core Alternative Capital opened a new position in iShares Core S&P 500 ETF worth $470K.
- Core Alternative Capital's largest Q1 2024 buy was iShares Core S&P 500 ETF: 894 shares worth $470K.
- Core Alternative Capital added most to Alphabet (Google) Class C in Q1 2024, an estimated $403K increase.
- Core Alternative Capital's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $4.75M.
- Core Alternative Capital fully exited Berkshire Hathaway Class A in Q1 2024, selling an estimated $543K.
- Core Alternative Capital's ten largest holdings make up 30% of its $558M portfolio in Q1 2024.
- Core Alternative Capital opened 17 new positions and closed 27 in Q1 2024.
- Core Alternative Capital's portfolio value fell 4.3% quarter-over-quarter to $558M.
Based on Core Alternative Capital's 13F filing for Q1 2024, filed 15 May 2024.